The Decision | GenomeWeb

The Decision

In some instances, such as when someone has an unknown genetic disease, sequencing the genome makes sense to get to the cause of the disease, the Wall Street Journal says, but it adds: What about when people are healthy? Stanford University's Atul Butte and Robert Green from Brigham and Women's Hospital and Harvard Medical School take up the debate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.